Redefining Patient Care in Acute Lymphoblastic Leukemia

Course Director, Daniel J. DeAngelo, MD, PhD, discusses acute lymphoblastic leukemia management in this CME activity titled "Redefining Patient Care in Acute Lymphoblastic Leukemia: The Impact of Novel Antibody and Immune Technologies on Clinical Outcomes." For the full presentation, downloadable practice aids and slides, complete CME information, and to apply for credit, please visit us at http://www.peerview.com/UHJ865. CME credit will be available until January 10, 2019.